Literature DB >> 11861399

Low-level microsatellite instability in most colorectal carcinomas.

Päivi Laiho1, Virpi Launonen, Päivi Lahermo, Manel Esteller, Mingzhou Guo, James G Herman, Jukka-Pekka Mecklin, Heikki Järvinen, Pertti Sistonen, Kyoung-Mee Kim, Darryl Shibata, Richard S Houlston, Lauri A Aaltonen.   

Abstract

Twelve to 16% of colorectal cancers (CRCs) display a high degree of microsatellite instability (MSI-H), whereas most are believed to be microsatellite stable (MSS). The existence of a low degree of instability (MSI-L) group has also been proposed. By using the Bethesda panel of microsatellite markers, the microsatellite instability (MSI) status of CRCs can be determined. This set is recommended to distinguish between MSI-H and MSI-L/MSS. No definition for MSI-L has emerged. Most reports on MSI-L rely on the Bethesda panel, using 5-15markers. Tumors with more than 30% MSI are designated as MSI-H, but the lower limit for MSI-L is ambiguous. We hypothesized that if many markers are studied, almost all CRCs would show some MSI. It would be necessary to establish a cutoff level for MSI-L by showing that, above this cutoff level, tumors display molecular and/or clinical features different from those under the cutoff level. To perform this task, we analyzed 90 BAT26 stable CRC samples with 377 markers. MSI at 1-11 loci was observed in 71 (79%) of the 90 cases. K-RAS mutation, loss of heterozygosity, and MLH1 and MGMT hypermethylation analyses were performed, as well as clinical features being scrutinized, to examine possible differences between MSI-L and MSS tumors using all of the possible cutoff levels for MSI-L. Convincing differences between putative MSI-L and MSS groups were not observed. Our results show that the sensitivity of a typically used marker number to detect MSI-L is very low, and they suggest that MSS and MSI-L tumors have a common molecular background.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  Association between recurrent metastasis from stage II and III primary colorectal tumors and moderate microsatellite instability.

Authors:  Melissa Garcia; Chan Choi; Hyeong-Rok Kim; Yahya Daoud; Yuji Toiyama; Masanobu Takahashi; Ajay Goel; C Richard Boland; Minoru Koi
Journal:  Gastroenterology       Date:  2012-03-27       Impact factor: 22.682

Review 2.  Microsatellite instability in colorectal cancer.

Authors:  C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

3.  Differences in genomic instability between intestinal- and diffuse-type gastric cancer.

Authors:  Matti Vauhkonen; Hanna Vauhkonen; Antti Sajantila; Pentti Sipponen
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

4.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.

Authors:  Mine S Cicek; Noralane M Lindor; Steven Gallinger; Bharati Bapat; John L Hopper; Mark A Jenkins; Joanne Young; Daniel Buchanan; Michael D Walsh; Loic Le Marchand; Terrilea Burnett; Polly A Newcomb; William M Grady; Robert W Haile; Graham Casey; Sarah J Plummer; Lisa A Krumroy; John A Baron; Stephen N Thibodeau
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

5.  Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary.

Authors:  Masayuki Nagahashi; Yoichi Ajioka; Istvan Lang; Zoltan Szentirmay; Miklos Kasler; Hiroto Nakadaira; Naoyuki Yokoyama; Gen Watanabe; Ken Nishikura; Toshifumi Wakai; Yoshio Shirai; Katsuyoshi Hatakeyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

Review 6.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Hypermutable DNA chronicles the evolution of human colon cancer.

Authors:  Kamila Naxerova; Elena Brachtel; Jesse J Salk; Aaron M Seese; Karen Power; Bardia Abbasi; Matija Snuderl; Sarah Chiang; Simon Kasif; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

8.  Classification and characterization of microsatellite instability across 18 cancer types.

Authors:  Ronald J Hause; Colin C Pritchard; Jay Shendure; Stephen J Salipante
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

9.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

10.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.